TABLE 4.
Clinical, lipids and inflammation parameters of the study population according to metabolic syndrome.
| Variable | Metabolic syndrome | |
|---|---|---|
| No (n = 198) | Yes (n = 132) | |
| Creatinine (umol/L) | 86.6 (84.4–88.9) | 85.9 (81.5–90.2) |
| Uric acid (umol/L) | 328.3 (315.3–341.4) | 388.2 (370.4–406.0) a |
| Albumin (g/L) | 44.7 (43.9–45.4) | 44.6 (44.8–45.4) |
| Direct bilirubin (U/L) | 2.5 (2.3–2.7) | 2.4 (2.2–2.7) |
| Total bilirubin (U/L) | 13.2 (12.1–14.2) | 12.2 (11.0–13.4) |
| AST (U/L) | 22.7 (21.0–24.4) | 23.3 (20.7–25.9) |
| ALT (U/L) | 25.1 (21.5–28.7) | 29.0 (24.9–33.1) |
| CK (U/L) | 107.6 (91.1–124.0) | 119.9 (88.5–151.3) |
| Gama GT (U/L) | 27.6 (23.4–31.8) | 38.8 (31.6–46.0) a |
| Microalbumine/Creatinine | 2.1 (0.75–3.4) | 8.1 (2.1–14.2) a |
| CRP * (mg/L) | 2.7 (1.3–6.0) | 4.7 (1.9–8.0) a |
| ESR * (mm/h) | 13.0 (6.0–20.0) | 18.5 (10.5–26.0) a |
Variables are presented as mean (95%CI).
*
Median (25–75th.Percentile).
a
p < 0.05.